Fig. 2From: Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)Consort diagram. FFPE formalin-fixed paraffin-embedded, IHC immunohistochemistry, MP Miller and Payne, pCR pathological complete response, SNP single nucleotide polymorphism. *Less tumor specimens available for performing IHC due to pCR of no tumor in the analyzed FFPE slideBack to article page